Max Robotics — Global Service Robot Directory + US Certification

About

Malene Rohrsted is a pioneering surgeon whose research is reshaping the landscape of urologic oncology and transplantation. Her work centers on the rigorous, evidence-based evaluation of robot-assisted surgery against traditional open techniques, particularly for radical cystectomy and kidney transplantation. Rohrsted leads the landmark BORARC trial, a double-blinded, randomised feasibility study comparing open versus robot-assisted radical cystectomy for bladder cancer—a methodologically bold approach that has already garnered over 40 citations. She has also been instrumental in advancing robot-assisted kidney transplantation (RAKT), contributing to a comprehensive European audit and a prospective multicenter study examining graft laterality. Her research consistently prioritizes patient-centered outcomes, including quality of life and complication rates, and she is spearheading the ORAKTx trial, the first randomised clinical trial to test whether RAKT can reduce surgical complications compared to open surgery. With over 115 total citations and a growing portfolio of high-impact protocols and feasibility studies, Rohrsted is a leading voice in the push for minimally invasive, evidence-driven surgical innovation in urology.